Endovascular myths: separating fact from fiction

This PVI 2025 session replay puts long-standing endovascular assumptions to the test. From the search for a final answer in aortoiliac occlusive disease (AIOD) management with covered endovascular reconstruction of the aortic bifurcation (CERAB) vs. kissing stents, to the question of whether common femoral artery (CFA) guidelines are stretching boundaries or still playing it safe, each presentation challenges a cornerstone of current practice. The discussion moves to the distal popliteal artery—does it remain a strict no-stenting zone?—before examining what the SWEDEPAD RCT truly means for real-world decision-making. The programme closes with a look at resorbable scaffolds and whether this long-promised technology is finally ready to deliver.

Tune in to spot which myths crack under data, and which still stand!